-
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
-
ChemBase ID:
72938
-
Molecular Formular:
C28H32O15
-
Molecular Mass:
608.54468
-
Monoisotopic Mass:
608.17412032
-
SMILES and InChIs
SMILES:
[C@@H]1([C@H]([C@@H](O[C@H]([C@@H]1O)C)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)Oc1cc2c(c(c1)O)c(=O)cc(o2)c1cc(c(cc1)OC)O)O)O)O)O)O
Canonical SMILES:
COc1ccc(cc1O)c1cc(=O)c2c(o1)cc(cc2O)O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](C)[C@@H]([C@H]([C@H]2O)O)O)[C@H]([C@@H]([C@H]1O)O)O
InChI:
InChI=1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1
InChIKey:
GZSOSUNBTXMUFQ-YFAPSIMESA-N
-
Cite this record
CBID:72938 http://www.chembase.cn/molecule-72938.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
|
|
|
|
|
IUPAC Traditional name
|
|
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
|
|
diosmin
|
|
|
|
|
Synonyms
|
|
Diosmetin 7-rutinoside
|
|
Daflon
|
|
Ven-Detrex
|
|
Salinigricoflavonoloside
|
|
Barosmin;
|
|
Diosmin
|
|
3′,5,7-Trihydroxy-4′-methoxyflavone 7-rutinoside
|
|
Diosmin
|
|
3′,5,7-三羟基-4′-甲氧基黄酮 7-芸香糖甙
|
|
地奥司明
|
|
|
|
|
CAS Number
|
|
|
EC Number
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
|
ATC CODE
|
|
|
CHEMBL
|
|
|
Chemspider ID
|
|
|
KEGG ID
|
|
|
Unique Ingredient Identifier
|
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
8.475596
|
H Acceptors
|
15
|
H Donor
|
8
|
LogD (pH = 5.5)
|
-0.4434314
|
LogD (pH = 7.4)
|
-0.47794226
|
Log P
|
-0.4429759
|
Molar Refractivity
|
142.3911 cm3
|
Polarizability
|
56.485394 Å3
|
Polar Surface Area
|
234.29 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
false
|
PROPERTIES
PROPERTIES
Safety Information
Pharmacology Properties
Product Information
Bioassay(PubChem)
|
Storage Condition
|
|
-20°C
|
Show
data source
|
|
|
MSDS Link
|
|
|
German water hazard class
|
|
3
|
Show
data source
|
|
|
Personal Protective Equipment
|
|
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
|
Show
data source
|
|
|
Storage Temperature
|
|
2-8°C
|
Show
data source
|
|
|
Mechanism of Action
|
|
Reduces the expression of endothelial adhesion molecules (ICAM1, VCAM1), and inhibits the adhesion, migration, and activation of leukocytes at the capillary level.
|
Show
data source
|
|
This leads to a reduction in the release of inflammatory mediators, principally oxygen free radicals and prostaglandins (PGE2, PGF2a).
|
Show
data source
|
|
|
Purity
|
|
≥90% (HPLC)
|
Show
data source
|
|
90%
|
Show
data source
|
|
|
Grade
|
|
analytical standard
|
Show
data source
|
|
technical grade
|
Show
data source
|
|
|
Salt Data
|
|
Free Base
|
Show
data source
|
|
|
Impurities
|
|
≤10% water
|
Show
data source
|
|
|
Biological Source
|
|
Isol. from Zanthoxylum avicennae, Diosma crenulata and others, first isol. from parsley
|
Show
data source
|
|
|
Shelf Life
|
|
(limited shelf life, expiry date on the label)
|
Show
data source
|
|
|
Application(s)
|
|
Antihaemorrhagic
|
Show
data source
|
|
Bioflavonoid
|
Show
data source
|
|
Venotonic
|
Show
data source
|
|
|
Empirical Formula (Hill Notation)
|
|
C28H32O15
|
Show
data source
|
|
DETAILS
DETAILS
Selleck Chemicals
Wikipedia
Sigma Aldrich
Selleck Chemicals -
S2292
|
Research Area: Cardiovascular Disease Biological Activity: Diosmin is a semisynthetic phlebotropic agent and a member of the flavonoid family.Diosmin prolongs the vasoconstrictor effect of norepinephrine on the vein wall, increasing venous tone, and therefore reducing venous capacitance, distensibility, and stasis. Diosmin increases the venous return and reduces venous hyperpressure present. Diosmin improves lymphatic drainage by increasing the frequency and intensity of lymphatic contractions, and by increasing the total number of functional lymphatic capillaries. Furthermore, diosmin with hesperidine decreases the diameter of lymphatic capillaries and the intralymphatic pressure. [1] |
Sigma Aldrich -
245313
|
Biochem/physiol Actions Citrus flavonoid. Modification of hesperidin. Studied for its chemopreventive properties, including anti-proliferative and anti-inflammatory. |
Sigma Aldrich -
61386
|
Biochem/physiol Actions Citrus flavonoid. Modification of hesperidin. Studied for its chemopreventive properties, including anti-proliferative and anti-inflammatory. |
Sigma Aldrich -
D3525
|
Frequently Asked Questions Live Chat and Frequently Asked Questions are available for this Product. Biochem/physiol Actions Citrus flavonoid. Modification of hesperidin. Studied for its chemopreventive properties, including anti-proliferative and anti-inflammatory. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • http://en.wikipedia.org/wiki/Diosmin
- • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 98C, (ir)
- • Lovecy, A. et al., J.C.S., 1930, 817, (synth)
- • Arthur, H.R. et al., J.C.S., 1956, 632, (Diosmin)
- • Horowitz, R.M. et al., J.O.C., 1956, 21, 1184, (isol)
- • Booth, A.N. et al., J. Biol. Chem., 1958, 230, 661, (metab)
- • Rsler, H. et al., J.O.C., 1965, 30, 4346, (pmr)
- • Plouvier, V., C. R. Hebd. Seances Acad. Sci. Ser. D, 1966, 263, 439, (isol, struct)
- • Brieskorn, C.H. et al., Arch. Pharm. (Weinheim, Ger.), 1971, 304, 557, (isol)
- • Wagner, H. et al., Tet. Lett., 1976, 1799, (cmr)
- • Oustrin, J. et al., Arzneim.-Forsch., 1977, 27, 1688, (pharmacol)
- • Le Quesne, P.W. et al., J.C.S. Perkin 1, 1978, 1572, (isol, uv, pmr)
- • Itokawa, H. et al., Chem. Lett., 1982, 1, 49, (ms)
- • Fujita, M. et al., Chem. Pharm. Bull., 1982, 30, 1151, (cmr)
- • Martindale, The Extra Pharmacopoeia, 28th/29th edn., Pharmaceutical Press, 1982, 12667
- • Voigtlnder, H.W. et al., Arch. Pharm. (Weinheim, Ger.), 1983, 316, 219, (synth)
- • Voirin, B., Phytochemistry, 1983, 22, 2107, (uv)
- • Rashid, M.A. et al., Fitoterapia, 1995, 66, 471, (Diosmin, pmr, cmr)
- • Bergan, J.J. et al., Angiology, 2001, 52, S43-S47, (diosmin, rev)
- • Garner, R.C. et al., J. Pharm. Sci., 2002, 91, 32-40, (diosmin, pharmacol)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent